Anti-atherosclerotic efficacy of olmesartan

Journal of Human Hypertension

Volumn 16, Issue , 2002, Pages S7-S12

  Miyazaki, M ^a   Takai, S ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Angiotensin II; Atherosclerosis; Monkey; Olmesartan; Receptor blocker

Indexed keywords

ACETYLCHOLINE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BIOLOGICAL MARKER; COLONY STIMULATING FACTOR 1; GROWTH FACTOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERCELLULAR ADHESION MOLECULE 1; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OLMESARTAN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; AORTA INTIMA; ATHEROSCLEROSIS; BLOOD PRESSURE; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; DRUG INHIBITION; FEMALE; LIPID BLOOD LEVEL; LIPID STORAGE; MACACA; MACROPHAGE MIGRATION INHIBITION; MALE; MONKEY; MYOCARDITIS; NONHUMAN; PROTEIN BLOOD LEVEL; VASCULAR ENDOTHELIUM;

ACETYLCHOLINE; ANGIOTENSIN II; ANIMALS; ANTIHYPERTENSIVE AGENTS; ARTERIOSCLEROSIS; BIOLOGICAL MARKERS; CHOLESTEROL; CHOLESTEROL, DIETARY; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; FEMALE; IMIDAZOLES; INFLAMMATION; LIPIDS; MACACA FASCICULARIS; MALE; RECEPTORS, ANGIOTENSIN; TETRAZOLES; TREATMENT OUTCOME;

EID: 0036111215     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001393     Document Type: Article

References (24)

1. Dzau VJ. Pathobiology of atherosclerosis and plaque complications. Am Heart J 1994; 128: 1300-1304.
2. Spence JD, Pesout AB, Melmon KL. Effects of antihypertensive drugs on blood velocity in rhesus monkeys. Stroke 1977; 8: 589-594.
3. Song K et al. Induction of angiotensin converting enzyme and angiotensin II receptors in the atherosclerotic aorta of high-cholesterol fed Cynomolgus monkeys. Atherosclerosis 1998; 138: 171-182.
4. Miyazaki M, Takai S. Antiatherosclerotic effect of ala-cepril, an angiotensin-converting enzyme inhibitor, in monkeys fed a high-cholesterol diet. Hypertens Res 1999; 22: 49-54.
5. Miyazaki M, Sakonjo H, Takai S. Anti-atherosclerotic effects of an angiotensin converting enzyme inhibitor and an angiotensin II antagonist in Cynomolgus monkeys fed a high-cholesterol diet. Br J Pharmacol 1999; 128: 523-529.
6. Hernandez-Presa M et al. Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis. Circulation 1997; 95: 1532-1541.
7. Warnholtz A et al. Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angio-tensin system. Circulation 1999; 99: 2027-2033.
8. Kim JA, Berliner JA, Nadler JL. Angiotensin II increases monocyte binding to endothelial cells. Biochem Biophys Res Commun 1996; 226: 862-868.
9. Nakano N et al. Negative regulation of local hepatocyte growth factor expression by angiotensin II and transforming growth factor-beta in blood vessels: potential role of HGF in cardiovascular disease. Hypertension 1998; 32: 444-451.
10. Nishimoto M et al. Chymase-dependent angiotensin II formation in the saphenous vein versus the internal thoracic artery. J Thorac Cardiovasc Surg 2001; 121: 729-734.
11. Sanz M, Ganado P, Ruiz E, Tejerina T. Effect of trando-lapril on vascular responsiveness in cholesterol-fed rabbit-isolated arteries. Eur J Pharmacol 2000; 397: 359-365.
12. Strawn WB et al. Inhibition of early atherogenesis by losartan in monkeys with diet-induced hypercholesterolemia. Circulation 2000; 101: 1586-1593.
13. Poston RN et al. Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am J Pathol 1992; 140: 665-673.
14. Rajavashisth TB et al. Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins. Nature 1990; 344: 254-257.
15. Ishibashi S et al. Monocyte colony-stimulating factor enhances uptake and degradation of acetylated low density lipoproteins and cholesterol esterification in human monocyte-derived macrophages. J Biol Chem 1990; 265: 14109-14117.
16. Weir MR, Dzau VJ. The renin-angiotensin-aldosterone system: a specific target for hypertension management. Am J Hypertens 1999; 12: 205S-213S.
17. Laviades C, Varo N, Diez J. Transforming growth factor beta in hypertensives with cardiorenal damage. Hypertension 2000; 36: 517-522.
18. Kiarash A et al. Upregulated expression of rat heart intercellular adhesion molecule-1 in angiotensin II-but not phenylephrine-induced hypertension. Hypertension 2001; 37: 58-65.
19. Okamura A et al. Upregulation of renin-angiotensin system during differentiation of monocytes to macrophages. J Hypertens 1999; 17: 537-545.
20. Fukuhara M et al. Angiotensin-converting enzyme expression in human carotid artery atherosclerosis. Hypertension 2000; 35: 353-359.
21. Keidar S. Angiotensin, LDL peroxidation and atherosclerosis. Life Sci 1998; 63: 1-11.
22. Chen XL et al. Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells. Circ Res 1998; 83: 952-959.
23. Scheidegger KJ, Butler S, Witztum JL. Angiotensin II increases macrophage-mediated modification of low density lipoprotein via a lipoxygenase-dependent pathway. J Biol Chem 1997; 272: 21609-21615.
24. Prasad A et al. Acute and chronic angiotensin-1 receptor antagonism reverses endothelial dysfunction in atherosclerosis. Circulation 2000; 101: 2349-2354.